Please enable JavaScript.
Coggle requires JavaScript to display documents.
Using the BNF (Prescribing
information (Indication
and dosing (Correct…
Using the BNF
Prescribing
information
-
-
-
-
Indication
and dosing
-
Correct route (PO, SC, IM, etc.)
Correct dose (age, BSA, weight, IBW)
found via searching condition or drug itself
-
-
-
Licencing
-
-
-
Unlicenced prescribing must satisify:
No suitable licenced alternative for pt need
Sufficient evidence/experience to support use
Take responsibility for pt care and monitoring
Document decision with rationaile and prescription
ADRs
General guidance details when to report,
how to prevent, and special reactions
-
MHRA (2014): in children <18 years.Yellow Card should be submitted for all serious ADRs to new drugs and vaccines that result in harm (fatal/life-threatening/disabling/incapacitating, congenital abnormality, or result in hospitalisation)
Introduction
-
-
-
-
-
Developed by Royal Pharmaceutical Society, BMA,
plus Royal College of Pediatrics
Basic principles
Drug monograph
-
-
-
-
-
-
-
-
-
-
-
-
-
Legal category
(prescription only, etc.)
-
-
-
Contents
-
Appendices - drug interactions, dental and nurse prescribing, community management of emergencies, BSA tables
-
Abbreviations, symbols and E numbers in back cover
Symbols
-
-
Half shaded box/crossed out 'NHS': less suitable for prescribing/not prescribable on the NHS (will be rejected by the pharmacy)
Black triangle: close monitoring by MHRA for SEs
(all new biologics or new active substance, all needing more monitoring after licencing, those subject to restrictions on safe use)
General guidance
-
-
-
How BNF made, changes since last
-
-
-
-
-